melanocytic naevi naevi
Conditions
Interventions
The participant will be administered with 532nmNd:YAG picosecond lazer
by the PQX pico lazer system into individual melanocytic naevi presented head, face, trunk, arm or leg by assigning the lesion.
therapy
Sponsors
Yuki Yamamoto
Kayo Kunimoto
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Male or female More than 1 month old. melanocytic naevi presented on the head, face, trunk, arm or leg.,who was diagnosed by skin biopsy.
Exclusion criteria
Exclusion criteria: Patient with having severe underlying disease, pre gnancy or lactation, Photosensivity, Porphyria, cardiac conduction disturbance, allergic conditioned, local anesthesia allergies, vascular or bleeding disorders, treatedwith anticoagulant therapy, autoimmune disease, t reated with immunosuppressive therapy, keloid sc ar formation, hypertrophic scar formation, maligna nt skin tumor, pigment anomaly, inflammatory dise ase that a symptom may aggravate in irritation by a treatment, medical history of herpesvirus infecti on. Invasive aesthetic treatments or surgery on the navi within 6 months prior to the study enrollment. Physical or chemical aesthetic treatments on the naevi within 3 month prior to the study enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall judgment of therapeutic efficacy | — |
Secondary
| Measure | Time frame |
|---|---|
| time-to-treatment-failure, adverse events | — |
Contacts
Public ContactKunimoto Kayo
Wakayama Medical University Hospital
Outcome results
None listed